Efficacy of two different doses of rabbit anti-T-lymphocyte globulin to prevent graft-versus-host disease in children with haematological malignancies transplanted from an unrelated donor: a multicentre, randomised, open-label, phase 3 trial-Reference-Cited by-同舟云学术

Efficacy of two different doses of rabbit anti-T-lymphocyte globulin to prevent graft-versus-host disease in children with haematological malignancies transplanted from an unrelated donor: a multicentre, randomised, open-label, phase 3 trial

Published:2017-08 Issue:8 Volume:18 Page:1126-1136
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Locatelli Franco,Bernardo Maria Ester,Bertaina Alice,Rognoni Carla,Comoli Patrizia,Rovelli Attilio,Pession Andrea,Fagioli Franca,Favre Claudio,Lanino Edoardo,Giorgiani Giovanna,Merli Pietro,Pagliara Daria,Prete Arcangelo,Zecca Marco

Publisher

Elsevier BV

Subject

Oncology

Reference33 articles.

1. Graft-versus-host disease;Ferrara;Lancet,2009

2. Impact of chronic graft-versus-host disease on late relapse and survival on 7,489 patients after myeloablative allogeneic hematopoietic cell transplantation for leukemia;Boyiadzis;Clin Cancer Res,2015

3. Chronic graft-versus-host disease in children: incidence, risk factors, and impact on outcome;Zecca;Blood,2002

4. Antithymocyte globulin for graft-versus-host disease prophylaxis in transplants from unrelated donors: 2 randomized studies from Gruppo Italiano Trapianti Midollo Osseo (GITMO);Bacigalupo;Blood,2001

5. Thymoglobulin prevents chronic graft-versus-host disease, chronic lung dysfunction, and late transplant-related mortality: long-term follow-up of a randomized trial in patients undergoing unrelated donor transplantation;Bacigalupo;Biol Blood Marrow Transplant,2006

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Model-Based Antithymocyte Globulin in αβhaplo-Hematopoietic Stem Cell Transplantation Facilitates Engraftment, Expedites T Cell Recovery, and Mitigates the Risk of Acute Graft-versus-Host Disease;Transplantation and Cellular Therapy;2024-08

2. Low-dose anti-thymocyte globulin plus low-dose posttransplant cyclophosphamide-based regimen for prevention of graft-versus-host disease in haploidentical peripheral blood stem cell transplantation for pediatric patients with hematologic malignancies;Annals of Hematology;2024-07-10

3. Anti-thymocyte globulin combined with post-transplantation cyclophosphamide reduce graft-versus-host disease in hematopoietic stem cell transplantation for pediatric leukemia;Leukemia & Lymphoma;2024-07-07

4. Outcomes of haploidentical peripheral blood stem cell transplantation following myeloablative conditioning using two types of rabbit ATG: a propensity score-matched analysis;Annals of Hematology;2024-03-02

5. Individualized dose of anti-thymocyte globulin based on weight and pre-transplantation lymphocyte counts in pediatric patients: a single center experience;Bone Marrow Transplantation;2024-01-22